Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu Meguro

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 13, 2012
[The significance of high sensitive C reactive protein as a risk factor for cardiovascular diseases]Shu Meguro, Midori Ishibashi, Izumi Takei
Current Medical Research and Opinion|August 2, 2019
Treatment preference for weekly versus daily DPP-4 inhibitors in patients with type 2 diabetes mellitus: outcomes from the TRINITY trialShu Meguro, Shingo Matsui, Hiroshi Itoh
Diabetology International|October 29, 2024
Effects of weight loss from oral semaglutide administration on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a retrospective analysis using propensity score matchingKazuki Aoyama, Yuya Nakajima, Shu Meguro, et al.
Journal of Diabetes Investigation|December 5, 2020
One-year estimated glomerular filtration rate decline as a risk factor of cardiovascular and renal end-points in high-risk Japanese patientsShu Meguro, Jun Inaishi, Yasunori Sato, et al.
Internal Medicine (Tokyo, Japan)|May 8, 2009
Increased risk of renal deterioration associated with low e-GFR in type 2 diabetes mellitus only in albuminuric subjectsShu Meguro, Toshikatsu Shigihara, Yusuke Kabeya, et al.
The Journal of Rheumatology|June 18, 2009
The presence of limited joint mobility is significantly associated with multiple digit involvement by stenosing flexor tenosynovitis in diabeticsMakoto Kameyama, Shu Meguro, Osamu Funae, et al.
Neuro Endocrinology Letters|March 23, 2017
A case of autoimmune polyendocrine syndrome type I with strong positive GAD antibody titer, followed up with glucose tolerance measured by oral glucose tolerance testRie Murakami, Toshihide Kawai, Shu Meguro, et al.
Endocrine Journal|May 31, 2023
Impact of coronavirus disease 2019 in seasonal variation of hemoglobin A1c in adults with type 1 diabetes and the effect of the mode of treatment: a single-center retrospective study for 2019 and 2021 and analysis by the mode of treatmentKarin Tanaka, Shu Meguro, Arata Itoh, et al.
Annals of Clinical Biochemistry|January 24, 2018
Difference of seasonal variation between glycated albumin and glycated haemoglobinKarin Tanaka, Shu Meguro, Masami Tanaka, et al.
Heliyon|March 20, 2019
Efficacy and safety of switching to insulin glargine 300 U/mL from 100 U/mL in Japanese patients with type 2 diabetes: A 12-month retrospective analysisKazutoshi Sugiyama, Shu Meguro, Yoshifumi Saisho, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 13, 2012
[The significance of high sensitive C reactive protein as a risk factor for cardiovascular diseases]Shu Meguro, Midori Ishibashi, Izumi Takei
Current Medical Research and Opinion|August 2, 2019
Treatment preference for weekly versus daily DPP-4 inhibitors in patients with type 2 diabetes mellitus: outcomes from the TRINITY trialShu Meguro, Shingo Matsui, Hiroshi Itoh
Diabetology International|October 29, 2024
Effects of weight loss from oral semaglutide administration on cardiometabolic risk factors in Japanese patients with type 2 diabetes: a retrospective analysis using propensity score matchingKazuki Aoyama, Yuya Nakajima, Shu Meguro, et al.
Journal of Diabetes Investigation|December 5, 2020
One-year estimated glomerular filtration rate decline as a risk factor of cardiovascular and renal end-points in high-risk Japanese patientsShu Meguro, Jun Inaishi, Yasunori Sato, et al.
Internal Medicine (Tokyo, Japan)|May 8, 2009
Increased risk of renal deterioration associated with low e-GFR in type 2 diabetes mellitus only in albuminuric subjectsShu Meguro, Toshikatsu Shigihara, Yusuke Kabeya, et al.
The Journal of Rheumatology|June 18, 2009
The presence of limited joint mobility is significantly associated with multiple digit involvement by stenosing flexor tenosynovitis in diabeticsMakoto Kameyama, Shu Meguro, Osamu Funae, et al.
Neuro Endocrinology Letters|March 23, 2017
A case of autoimmune polyendocrine syndrome type I with strong positive GAD antibody titer, followed up with glucose tolerance measured by oral glucose tolerance testRie Murakami, Toshihide Kawai, Shu Meguro, et al.
Endocrine Journal|May 31, 2023
Impact of coronavirus disease 2019 in seasonal variation of hemoglobin A1c in adults with type 1 diabetes and the effect of the mode of treatment: a single-center retrospective study for 2019 and 2021 and analysis by the mode of treatmentKarin Tanaka, Shu Meguro, Arata Itoh, et al.
Annals of Clinical Biochemistry|January 24, 2018
Difference of seasonal variation between glycated albumin and glycated haemoglobinKarin Tanaka, Shu Meguro, Masami Tanaka, et al.
Heliyon|March 20, 2019
Efficacy and safety of switching to insulin glargine 300 U/mL from 100 U/mL in Japanese patients with type 2 diabetes: A 12-month retrospective analysisKazutoshi Sugiyama, Shu Meguro, Yoshifumi Saisho, et al.
Pageof 6